Maribavir

CAS: 176161-24-3

Ref. TM-T2162

Produktinformation

• Name: Maribavir
• Synonyme: BW1263W94, GW257406X, Benzimidavir, 1263W94, 1263W94, 1H-Benzimidazol-2-amine, 5,6-dichloro-N-(1-methylethyl)-1-β-<span class="text-smallcaps">L</span>-ribofuranosyl-, 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl)-1H-Benzimidazole, 5,6-Dichloro-2-Isopropylamino-1-(-L-Ribofuranosyl)-Lh-Benzimidazole, 5,6-Dichloro-N-(1-methylethyl)-1-β-<span class="text-smallcaps">L</span>-ribofuranosyl-1H-benzimidazol-2-amine, 5,6-dichloro-1-[(1S)-pentofuranosyl]-N-(propan-2-yl)-1H-benzimidazol-2-amine, 5,6-dichloro-N-(1-methylethyl)-1-beta-L-ribofuranosyl-1H-benzimidazol-2-amine, BENZIMIDAVIR, 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-LH-BENZIMIDAZOLE, Benzimidavir: 5,6-Dichloro-2-(Isopropylamino)-1-(Ss-L-Ribofuranosyl)-Lh-Benzimidazole, Bw 1263W94, Gw 257406X
• CAS: 176161-24-3

Beschreibung

Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 376.24
• Formel: C₁₅H₁₉Cl₂N₃O₄
• Reinheit: 100%
• Farbe/Form: Solid